Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![ETNOWlive Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::225012752.png) ET NOW [@ETNOWlive](/creator/twitter/ETNOWlive) on x 871.1K followers
Created: 2025-07-23 14:53:55 UTC

#Q1WithETNOW | Dr. Reddy's Lab management on #Q1Results: India drives double-digit growth as U.S. Lenalidomide wind-down weighs; semaglutide launch on track for Q4

#Pharma #Earnings #GLP1 #IndiaGrowth

![](https://pbs.twimg.com/media/GwjOXfWacAEURJn.jpg)

XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1948033841203150968/c:line.svg)

**Related Topics**
[launch on](/topic/launch-on)
[semaglutide](/topic/semaglutide)
[india](/topic/india)
[dr reddys](/topic/dr-reddys)

[Post Link](https://x.com/ETNOWlive/status/1948033841203150968)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

ETNOWlive Avatar ET NOW @ETNOWlive on x 871.1K followers Created: 2025-07-23 14:53:55 UTC

#Q1WithETNOW | Dr. Reddy's Lab management on #Q1Results: India drives double-digit growth as U.S. Lenalidomide wind-down weighs; semaglutide launch on track for Q4

#Pharma #Earnings #GLP1 #IndiaGrowth

XXXXX engagements

Engagements Line Chart

Related Topics launch on semaglutide india dr reddys

Post Link

post/tweet::1948033841203150968
/post/tweet::1948033841203150968